Bank of New York Mellon’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
89,998
+8,672
+11% +$85.9K ﹤0.01% 3340
2026
Q1
$749K Buy
81,326
+1,773
+2% +$14.8K ﹤0.01% 3390
2025
Q4
$591K Sell
79,553
-2,946
-4% -$20.2K ﹤0.01% 3514
2025
Q3
$560K Sell
82,499
-410
-0.5% -$2.77K ﹤0.01% 3525
2025
Q2
$573K Buy
82,909
+2,768
+3% +$18.8K ﹤0.01% 3435
2025
Q1
$583K Buy
80,141
+8,711
+12% +$68.4K ﹤0.01% 3371
2024
Q4
$573K Sell
71,430
-504
-0.7% -$4.37K ﹤0.01% 3452
2024
Q3
$527K Sell
71,934
-23,454
-25% -$168K ﹤0.01% 3489
2024
Q2
$625K Buy
95,388
+9,792
+11% +$73.8K ﹤0.01% 3450
2024
Q1
$807K Buy
85,596
+7,774
+10% +$66.6K ﹤0.01% 3262
2023
Q4
$611K Sell
77,822
-711
-0.9% -$5.16K ﹤0.01% 3442
2023
Q3
$529K Buy
78,533
+1,415
+2% +$11.6K ﹤0.01% 3515
2023
Q2
$754K Buy
+77,118
New +$783K ﹤0.01% 3372
2022
Q2
Sell
-116,431
Closed -$580K 4706
2022
Q1
$580K Sell
116,431
-1,404
-1% -$6.52K ﹤0.01% 3627
2021
Q4
$615K Buy
117,835
+3,050
+3% +$17K ﹤0.01% 3661
2021
Q3
$637K Buy
114,785
+6,814
+6% +$44.3K ﹤0.01% 3662
2021
Q2
$772K Buy
107,971
+13,967
+15% +$121K ﹤0.01% 3566
2021
Q1
$951K Sell
94,004
-69
-0.1% -$649 ﹤0.01% 3361
2020
Q4
$729K Buy
94,073
+10,819
+13% +$95.2K ﹤0.01% 3435
2020
Q3
$719K Sell
83,254
-466
-0.6% -$4.7K ﹤0.01% 3308
2020
Q2
$803K Buy
+83,720
New +$651K ﹤0.01% 3227

Other funds holding VMD

Bank of New York Mellon's VMD Position: Q2 2026 in Review

Bank of New York Mellon increased its Viemed Healthcare (VMD) stake by 11% in Q2 2026, buying an estimated $85.9K and bringing the position to 89,998 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

Bank of New York Mellon first reported a position in VMD in Q2 2020 and has held it in 21 quarters since. 100 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Bank of New York Mellon held 89,998 shares of Viemed Healthcare worth $1.03M as of Q2 2026.
  • Bank of New York Mellon bought 8,672 Viemed Healthcare shares in Q2 2026, an estimated $85.9K.
  • Viemed Healthcare made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3340 holding.
  • Bank of New York Mellon first reported a position in Viemed Healthcare in Q2 2020 and has held it in 21 quarters since.
  • 100 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.